Diabetic nephropathy is accelerated by farnesoid X receptor deficiency and inhibited by farnesoid X receptor activation in a type 1 diabetes model

…, T Jiang, Y Shen, Y Caldas, S Miyazaki-Anzai… - Diabetes, 2010 - Am Diabetes Assoc
OBJECTIVE The pathogenesis of diabetic nephropathy is complex and involves activation of
multiple pathways leading to kidney damage. An important role for altered lipid metabolism …

The farnesoid X receptor modulates renal lipid metabolism and diet-induced renal inflammation, fibrosis, and proteinuria

…, L Lewis, S Miyazaki-Anzai… - American Journal …, 2009 - journals.physiology.org
… The signal transduction of TGF-β is regulated via a heteromeric complex of type I and type
II TGF-β receptors. The type II receptor is the primary binding protein for ligands and is the …

[HTML][HTML] Synthetic LXR agonist attenuates plaque formation in apoE-/-mice without inducing liver steatosis and hypertriglyceridemias⃞

…, TM Becker, G Uray, M Miyazaki, S Miyazaki-Anzai… - Journal of lipid …, 2009 - ASBMB
Liver X receptors (LXRs) are important regulators of cholesterol and lipid metabolism. LXR
agonists have been shown to limit the cellular cholesterol content by inducing reverse …

PERK‐eIF2α‐ATF 4‐CHOP signaling Contributes to TNF α‐Induced vascular Calcification

M Masuda, S MiyazakiAnzai, M Levi… - Journal of the …, 2013 - Am Heart Assoc
… The upper band is the expression of unspliced forms of XBP ‐1 m RNA (u XBP ‐1) and
the lower is the expression of spliced forms of XBP ‐1 m RNA (s XBP ‐1). ***P<0.001. ALP …

Synthetic farnesoid X receptor agonists induce high-density lipoprotein-mediated transhepatic cholesterol efflux in mice and monkeys and prevent atherosclerosis in …

…, S Miyazaki-Anzai, U Hahn, S Matysik… - … of Pharmacology and …, 2012 - ASPET
… Activation of FXR is reported to lead to both pro- and anti-atherosclerotic effects. In the … That
pharmacological FXR activation specifically affects this cholesterol-rich HDL 2 subclass is a …

[HTML][HTML] Dual activation of the bile acid nuclear receptor FXR and G-protein-coupled receptor TGR5 protects mice against atherosclerosis

S Miyazaki-Anzai, M Masuda, M Levi, AL Keenan… - PloS one, 2014 - journals.plos.org
… We hypothesized that dual activation of FXR and TGR5 is effective in the prevention of
atherosclerotic formation. In this study, we examined the pharmacologic effects of simultaneous …

[HTML][HTML] Identification of cholesterol crystals in plaques of atherosclerotic mice using hyperspectral CARS imaging

RS Lim, JL Suhalim, S Miyazaki-Anzai, M Miyazaki… - Journal of lipid …, 2011 - ASBMB
The accumulation of lipids, including cholesterol, in the arterial wall plays a key role in the
pathogenesis of atherosclerosis. Although several advances have been made in the detection …

Farnesoid X Receptor Activation Prevents the Development of Vascular Calcification in ApoE−/− Mice With Chronic Kidney Disease

S Miyazaki-Anzai, M Levi, A Kratzer, TC Ting… - Circulation …, 2010 - Am Heart Assoc
… In this study, we examined which nuclear receptor(s) is involved in the development of
vascular calcification, a major complication in subjects with CKD and a strong predictor of …

Endoplasmic Reticulum Stress Effector CCAAT/Enhancer‐binding Protein Homologous Protein (CHOP) Regulates Chronic Kidney Disease–Induced Vascular …

S MiyazakiAnzai, M Masuda… - Journal of the …, 2014 - Am Heart Assoc
… Oxidized low‐density lipoprotein (LDL) is present in atherosclerotic and calcified plaques
and is thought to play an important role in the development of atherosclerosis and vascular …

[HTML][HTML] Saturated phosphatidic acids mediate saturated fatty acid–induced vascular calcification and lipotoxicity

M Masuda, S Miyazaki-Anzai… - The Journal of …, 2015 - Am Soc Clin Investig
is common in VSMCs of murine models of vascular calcification. The reduction of klotho, an
aging-related protein, is … of SCD induced by klotho deficiency is a major event in vascular …